Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

MLC901 for Moderate to Severe Traumatic Brain Injury: Pilot, Randomized, Double-Masked, Placebo-controlled Trial

NCT04487275 is registered in ClinicalTrials.gov with Ali Amini Harandi as lead sponsor.

NCT NCT04487275
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04487275 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
MLC901 for Moderate to Severe Traumatic Brain Injury: Pilot, Randomized, Double-Masked, Placebo-controlled Trial
Lead sponsor
Ali Amini Harandi
Phase
Phase 4
Overall status
Unknown status
Start date
August 20, 2018
Completion date
October 31, 2020
Enrollment
80 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

traumatic brain injury